Journal
EUROPEAN HEART JOURNAL
Volume 36, Issue 20, Pages 1223-1230Publisher
OXFORD UNIV PRESS
DOI: 10.1093/eurheartj/ehv051
Keywords
Shock; Heart failure; Treatment; Percutaneous coronary intervention; Myocardial infarction; Assist device
Categories
Ask authors/readers for more resources
Cardiogenic shock (CS) remains the most common cause of death in patients with acute myocardial infarction although mortality could be reduced from formerly similar to 80% to 40-50%. In addition to percutaneous coronary intervention or coronary artery bypass grafting, catecholamines, fluids, intraaortic balloon pumping (IABP), and also active assist devices are widely used for CS management. However, there is only limited evidence for any of the above treatments except for early revascularization and the relative ineffectiveness of IABP. This updated review will therefore outline the management of CS complicating acute myocardial infarction with major focus on evidence-based revascularization techniques, intensive care unit treatment including ventilation, transfusion regimens, adjunctive medication, and mechanical support devices.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available